Document is current
Any future updates will be listed below
-
Authors
Rajendran, Suraj https://orcid.org/0000-0002-8149-0157
Brendel, Matthew https://orcid.org/0000-0003-3417-4597
Barnes, Josue
Zhan, Qiansheng https://orcid.org/0000-0001-7130-7606
Malmsten, Jonas E. https://orcid.org/0000-0001-6740-6548
Zisimopoulos, Pantelis https://orcid.org/0009-0006-2425-0882
Sigaras, Alexandros https://orcid.org/0000-0002-7607-559X
Ofori-Atta, Kwabena
Meseguer, Marcos
Miller, Kathleen A. https://orcid.org/0000-0003-0352-470X
Hoffman, David
Rosenwaks, Zev
Elemento, Olivier https://orcid.org/0000-0002-8061-9617
Zaninovic, Nikica
Hajirasouliha, Iman https://orcid.org/0000-0002-0600-3371
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM138152)
- License Information
-
More Information
Article History
Received: 3 August 2023
Accepted: 15 August 2024
First Online: 5 September 2024
Competing interests
: O.E. is a scientific adviser for, and an equity holder in, Freenome, Owkin, Volastra Therapeutics, OneThree Biotech, Genetic Intelligence, Acuamark DX, Harmonic Discovery, and Champions Oncology, and has received funding from Eli Lilly, Johnson & Johnson–Janssen, Sanofi, AstraZeneca, and Volastra. N.Z. is a paid consultant for AIVF and Fairtility, and is on the advisory board of, and has equity in, Alife Health. I.H. is a consultant and is on the advisory board of Noor Sciences. S.R., J.B., J.E.M., Z.R., O.E., N.Z. and I.H. are listed as inventors on a provisional patent filed by Cornell University (application number 63/484,177) about the technology described in this study. M.M. received speaker fees from Merck, Vitrolife, Ferring, Theramex, and Gideon Richter. P.Z. holds stocks in Pfizer and Bristol Myers Squibb. K.A.M. serves as a paid consultant and advisory board member for Fairtility and Alife Health (holding equity), and as a scientific board member for Genomic Prediction and Igenomix. The remaining authors declare no competing interests.
